Home›Companies›Healthcare›Acurion

Acurion, Inc.

Acurion develops AI tools that help oncologists identify cancer biomarkers from tissue slides.

Updated Nov 10, 2026·Latest SEC filing Apr 16, 2026·Suggest an edit

About Acurion

Acurion is a private company based in San Diego, California, incorporated in 2026 in Delaware. It has reported $4,139,984 raised in one offering on Form D since April 2026. Its chief executive is Frederick Fultz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 17, 2026Apr 16, 2026$4,139,984of $4.5M target36$114KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Acurion's Form D filed Apr 16, 2026.

Magda Marquet
Magda Marquet
Board Member, Co-Founder
Also a board member at Alume Biosciences.
Webster Cavenee
Webster Cavenee
Board Member, Co-Founder
FF
Frederick Fultz
CEO and director
FF

Sources

  1. SECAcurion, Inc. filing history
  2. CompanyAcurion leadership team
  3. CompanyAcurion seed financing announcement